| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
3,578.55
|
|
Change (%)
|
18.75 (0.53%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
3,521.20
-
3,614.65
|
|
52-Week Range (RS)
|
3,151.05
-
6,717.50
|
|
Beta (1 Year)
|
0.47
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Board of Sanofi India recommends final dividend |
| Sanofi India standalone net profit declines 32.42% in the December 2025 quarter |
| Sanofi India to hold board meeting |
| Sanofi India Ltd - Sanofi India Limited - Record Date |
| Sanofi India Ltd - Sanofi India Limited - Copy of Newspaper Publication |
| Board of Sanofi India recommends Interim Dividend |
| Sanofi India standalone net profit declines 7.54% in the September 2025 quarter |
| Board of Sanofi India approves change in directorate |
| Sanofi India Ltd - Sanofi India Limited - Press Release |
| Sanofi India Ltd - Sanofi India Limited - Cessation |
|
|
|
| Incoporation Year : 1956 |
| Chairman : Aditya Narayan |
| Ownership Group : MNC Asc-Hoechst |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Sanofi India Ltd
Sanofi Hse 117-B Saki Vihar Rd,
L&T Business Park Powai,
Mumbai,
Maharashtra-400072 |
Phone:91-22-28032000
Fax:91-22-28032939 |
| E-Mail : igrc.sil@sanofi.com |
| URL : http://www.sanofiindialtd.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
13-Apr-2026 |
3465.50 |
3.26 |
| 1Month |
20-Mar-2026 |
3385.30 |
5.71 |
| 3Month |
20-Jan-2026 |
4058.35 |
-11.82 |
| 6Month |
20-Oct-2025 |
4694.05 |
-23.76 |
| 1Year |
21-Apr-2025 |
6306.45 |
-43.26 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Contra Fund |
0.18 |
80.75 |
| Aditya Birla SL Large Cap Fund |
0.30 |
80.36 |
| Nippon India Pharma Fund |
0.94 |
73.91 |
| Nippon India Growth Mid Cap Fund |
0.18 |
72.79 |
| Nippon India Small Cap Fund |
0.11 |
68.69 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
25,578.90 |
-0.85 |
35,921.55 |
25,318.30 |
54,355.16 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,432.10 |
-0.80 |
3,515.95 |
2,218.00 |
41,201.24 |
| Pfizer Ltd |
4,891.60 |
-1.26 |
5,987.65 |
4,123.50 |
22,377.96 |
| Astrazeneca Pharma India Ltd |
8,519.80 |
0.13 |
10,653.05 |
7,630.00 |
21,299.50 |
| Sanofi Consumer Healthcare India Ltd |
4,723.05 |
0.01 |
5,954.00 |
3,950.50 |
10,877.48 |
|
|
|
|